MIR - Medical International Research S.p.A.

MIR (Medical International Research S.p.A.) is an Italian medical device manufacturer with over 30 years of experience specializing in spirometry, oximetry, and cardiology solutions for respiratory and cardiovascular health management. The company operates in more than 100 countries and offers an integrated portfolio spanning professional clinical-use devices for hospitals and medical centers, as well as personal-use smartphone-compatible smart devices for home monitoring and proactive health management. MIR's regulatory credentials include FDA clearance for the United States, NMPA (China), ANVISA (Brazil), COFEPRIS (Mexico), Health Canada, and other international certifications, ensuring compliance with the highest quality standards. The company is internationally recognized for patented product designs and maintains constant investment in research and development. MIR's product lines include spirometers (Spirobank series, Spirodoc, Spirolab variants), oximeters (Smart One Oxi), and the Cardionica cardiology line. Software offerings include MIR Spiro Platinum, a comprehensive desktop/laptop platform for spirometry and oximetry data management, integrated with EMR/EHR systems and compliant with ATS/ERS guidelines. The company also supplies accessories, consumables, and turbine components. MIR serves pulmonologists, allergists, occupational health professionals, and institutional buyers including the UK's National Health Service (NHS). Manufacturing and service capabilities include device calibration, technical support, developer program access for OEM/ODM partnerships, and an established dealer network.